Global and China Pulmonary Drugs Market Research by Company, Type & Application 2013-2025

Table of Content

1 Market Overview

• 1.1 Market Segment Overview
  • 1.1.1 Product Definition
  • 1.1.2 Market by Type
    • 1.1.2.1 Inhaled Corticosteroids (ICS)
    • 1.1.2.2 Long-Acting Beta2-Agonists (LABA)
    • 1.1.2.3 Antihistamine
    • 1.1.2.4 Vasodilators
    • 1.1.2.5 Short-Acting Beta2-Agonists (SABA)
    • 1.1.2.6 Anticholinergics
    • 1.1.2.7 Combination Drugs
    • 1.1.2.8 MAbs
    • 1.1.2.9 Enzymes
    • 1.1.2.10 Antibiotics & Antileukotrienes
  • 1.1.3 Market by Application
    • 1.1.3.1 Asthma & COPD
    • 1.1.3.2 Allergic Rhinitis
    • 1.1.3.3 Pulmonary Arterial Hypertension
    • 1.1.3.4 Cystic Fibrosis
• 1.2 Global and China Market Size
  • 1.2.1 Global Overview
  • 1.2.2 China Overview

2 Global and China Market by Company

• 2.1 Global
  • 2.1.1 Global Sales by Company
  • 2.1.2 Global Price by Company
• 2.2 China
  • 2.2.1 China Sales by Company
  • 2.2.2 China Price by Company

3 Global and China Market by Type

• 3.1 Global
  • 3.1.1 Global Sales by Type
  • 3.1.2 Global Price by Type
• 3.2 China
  • 3.2.1 China Sales by Type
  • 3.2.2 China Price by Type

4 Global and China Market by Application

• 4.1 Global
  • 4.1.1 Global Sales by Application
  • 4.1.2 Global Price by Application
• 4.2 China
  • 4.2.1 China Sales by Application
  • 4.2.2 China Price by Application

5 China Trade

• 5.1 Export
• 5.2 Import

6 Key Manufacturers

• 6.1 AstraZeneca plc
  • 6.1.1 Company Information
  • 6.1.2 Product Specifications
  • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 6.2 Bayer AG
• 6.3 Teva Pharmaceutical Industries Ltd
• 6.4 Actelion Pharmaceuticals, Inc.
• 6.5 Boehringer Ingelheim GmbH
• 6.6 F. Hoffmann-La Roche Ltd.
• 6.7 Merck & Co., Inc.
• 6.8 Novartis AG
• 6.9 GlaxoSmithKline plc
• 6.10 Sunovion Pharmaceuticals

7 Industry Upstream

• 7.1 Industry Chain
• 7.2 Raw Materials

8 Market Environment

• 8.1 SWOT
• 8.2 Porter's Five Forces

9 Conclusion